Vitamin D, Taxotere Combination Promising For Advanced Prostate Cancer
Prostate Cancer Treatment
Results of a new study strongly suggest that DN-101, a new high-dose calcitriol pill designed specifically as a cancer therapy, given in combination with docetaxel (Taxotere) extends the lives of men with advanced prostate cancer. And, the toxicity of the combination therapy proved to be no greater than for research subjects who received docetaxel alone. Calcitriol is a naturally occurring hormone and the biologically active form of vitamin D.
"The data strongly suggest that DN-101, given in combination with docetaxel, will provide a substantial survival benefit to prostate cancer patients without adding toxicity," said Tomasz Beer, M.D., national leader of the clinical trial and director of the Prostate Cancer Program in the Oregon Health